Chiranjib Chakraborty

InstitutionAdamas University
AddressIndia
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 27 Covid-19 publications, with a maximum of 4 publications in May 2020 and January 2021 and June 2021
    All Publications
    Bar chart showing 156 publications over 23 distinct years, with a maximum of 20 publications in 2014
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. mBio. 2021 08 31; 12(4):e0114021. PMID: 34465019.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    2. Chakraborty C, Sharma AR, Bhattacharya M, Lee SS. Lessons Learned from Cutting-Edge Immunoinformatics on Next-Generation COVID-19 Vaccine Research. Int J Pept Res Ther. 2021; 27(4):2303-2311. PMID: 34276266.
      Citations:    
    3. Chakraborty C, Sharma AR, Bhattacharya M, Lee SS. From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape. Front Immunol. 2021; 12:679344. PMID: 34305909.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    4. Chakraborty C, Bhattacharya M, Sharma AR, Lee SS, Agoramoorthy G. SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection. Ann Med Surg (Lond). 2021 Jun; 66:102428. PMID: 34109031.
      Citations: 4     
    5. Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. Asian-Origin Approved COVID-19 Vaccines and Current Status of COVID-19 Vaccination Program in Asia: A Critical Analysis. Vaccines (Basel). 2021 Jun 04; 9(6). PMID: 34199995.
      Citations: 2     
    6. Shawan MMAK, Sharma AR, Bhattacharya M, Mallik B, Akhter F, Shakil MS, Hossain MM, Banik S, Lee SS, Hasan MA, Chakraborty C. Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2. Infect Genet Evol. 2021 09; 93:104951. PMID: 34089909.
      Citations: 2     Fields:    Translation:HumansCells
    7. Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. All Nations Must Prioritize the COVID-19 Vaccination Program for Elderly Adults Urgently. Aging Dis. 2021 Jun; 12(3):688-690. PMID: 34094633.
      Citations: 1     
    8. Chakraborty C, Sharma AR, Bhattacharya M, Agoramoorthy G, Lee SS. The current second wave and COVID-19 vaccination status in India. Brain Behav Immun. 2021 Aug; 96:1-4. PMID: 34022371.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    9. Chakraborty C, Ranjan Sharma A, Bhattacharya M, Lee SS, Agoramoorthy G. COVID-19 vaccine: Challenges in developing countries and India's initiatives. Infez Med. 2021 Mar 01; 29(1):165-166. PMID: 33664189.
      Citations: 1     Fields:    Translation:Humans
    10. Chakraborty C, Sharma AR, Mallick B, Bhattacharya M, Sharma G, Lee SS. Evaluation of molecular interaction, physicochemical parameters and conserved pattern of SARS-CoV-2 Spike RBD and hACE2: in silico and molecular dynamics approach. Eur Rev Med Pharmacol Sci. 2021 02; 25(3):1708-1723. PMID: 33629340.
      Citations: 1     Fields:    Translation:HumansCells
    11. Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Lee SS. Immunoinformatics Approach for the Identification and Characterization of T Cell and B Cell Epitopes towards the Peptide-Based Vaccine against SARS-CoV-2. Arch Med Res. 2021 05; 52(4):362-370. PMID: 33546870.
      Citations: 4     Fields:    Translation:Humans
    12. Chakraborty C, Bhattacharya M, Mallick B, Sharma AR, Lee SS, Agoramoorthy G. SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development. Expert Rev Clin Pharmacol. 2021 Feb; 14(2):225-238. PMID: 33423554.
      Citations: 5     Fields:    Translation:Humans
    13. Chakraborty C, Sharma AR, Bhattacharya M, Saha RP, Ghosh S, Biswas S, Samanta S, Sharma G, Agoramoorthy G, Lee SS. SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics. Infect Genet Evol. 2021 04; 89:104729. PMID: 33497837.
      Citations:    Fields:    Translation:HumansCells
    14. Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Saha RP, Lee SS. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic. Immune Netw. 2021 Feb; 21(1):e5. PMID: 33728098.
      Citations: 2     
    15. Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Agoramoorthy G, Lee SS. Diabetes and COVID-19: a major challenge in pandemic period? Eur Rev Med Pharmacol Sci. 2020 11; 24(21):11409-11420. PMID: 33215463.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    16. Chakraborty C, Agoramoorthy G. India's cost-effective COVID-19 vaccine development initiatives. Vaccine. 2020 11 25; 38(50):7883-7884. PMID: 33129610.
      Citations: 5     Fields:    Translation:HumansAnimals
    17. Bhattacharya M, Sharma AR, Mallick B, Sharma G, Lee SS, Chakraborty C. Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex. Infect Genet Evol. 2020 11; 85:104587. PMID: 33039603.
      Citations: 22     Fields:    Translation:HumansCells
    18. Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Response to: Status of Remdesivir: Not Yet Beyond Question! Arch Med Res. 2021 01; 52(1):104-106. PMID: 32948379.
      Citations: 2     Fields:    Translation:Humans
    19. Saha RP, Sharma AR, Singh MK, Samanta S, Bhakta S, Mandal S, Bhattacharya M, Lee SS, Chakraborty C. Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19. Front Pharmacol. 2020; 11:1258. PMID: 32973505.
      Citations: 35     
    20. Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC, Saha RP, Lee SS, Chakraborty C. A SARS-CoV-2 vaccine candidate: In-silico cloning and validation. Inform Med Unlocked. 2020; 20:100394. PMID: 32835079.
      Citations: 21     
    21. Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Agoramoorthy G. COVID-19: Consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients. J Med Virol. 2020 11; 92(11):2260-2262. PMID: 32462717.
      Citations: 25     Fields:    Translation:Humans
    22. Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Saha RP, Lee SS. Extensive Partnership, Collaboration, and Teamwork is Required to Stop the COVID-19 Outbreak. Arch Med Res. 2020 10; 51(7):728-730. PMID: 32532523.
      Citations: 23     Fields:    Translation:HumansPHPublic Health
    23. Chakraborty C, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Agoramoorthy G. Consider TLR5 for new therapeutic development against COVID-19. J Med Virol. 2020 11; 92(11):2314-2315. PMID: 32391920.
      Citations: 29     Fields:    Translation:Humans
    24. Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Tocilizumab: A Therapeutic Option for the Treatment of Cytokine Storm Syndrome in COVID-19. Arch Med Res. 2020 08; 51(6):595-597. PMID: 32482373.
      Citations: 35     Fields:    Translation:HumansCellsPHPublic Health
    25. Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee SS, Chakraborty C. Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More. Arch Med Res. 2020 08; 51(6):585-586. PMID: 32439198.
      Citations: 48     Fields:    Translation:HumansCellsPHPublic Health
    26. Chakraborty C, Sharma AR, Sharma G, Bhattacharya M, Lee SS. SARS-CoV-2 causing pneumonia-associated respiratory disorder (COVID-19): diagnostic and proposed therapeutic options. Eur Rev Med Pharmacol Sci. 2020 04; 24(7):4016-4026. PMID: 32329877.
      Citations: 99     Fields:    Translation:HumansCellsPHPublic Health
    27. Bhattacharya M, Sharma AR, Patra P, Ghosh P, Sharma G, Patra BC, Lee SS, Chakraborty C. Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach. J Med Virol. 2020 06; 92(6):618-631. PMID: 32108359.
      Citations: 139     Fields:    Translation:HumansCellsPHPublic Health
    Chakraborty's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (166)
    Explore
    _
    Co-Authors (36)
    Explore
    _
    Similar People (60)
    Explore
    _